TH98075B - Anti-TSLP Antibody - Google Patents
Anti-TSLP AntibodyInfo
- Publication number
- TH98075B TH98075B TH701000781A TH0701000781A TH98075B TH 98075 B TH98075 B TH 98075B TH 701000781 A TH701000781 A TH 701000781A TH 0701000781 A TH0701000781 A TH 0701000781A TH 98075 B TH98075 B TH 98075B
- Authority
- TH
- Thailand
- Prior art keywords
- htslp
- antibodies
- tslp
- tslp antibody
- adheres
- Prior art date
Links
- 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 claims 3
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 208000017604 Hodgkin disease Diseases 0.000 abstract 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 abstract 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 210000004324 lymphatic system Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Abstract
การประดิษฐ์นี้เกี่ยวข้องกับแอนตี้บอดี้ต่อระบบน้ำเหลืองส่วนพยุงต่อมไธมัสของมนุษย์ (hTSLP) และโดยเฉพาะอย่างยิ่งสิ่งเหล่านั้นซึ่งนิวทรอลไลซ์แอคติวิตี้ hTSLP สิ่งนี้ยังเกี่ยวข้อง กับวิธีการสำหรับการใช้โมเลกุลแอนตี้-hTSLP แอนตี้บอดี้ในการวินิจฉัยหรือการรักษาความผิดปกติ ที่เกี่ยวข้องกับ hTSLP , เช่น โรคหอบหืด, โรคผิวหนังอักเสบเฉพาะที่, โรคเยื่อจมูกอักเสบเนื่องจาก ภูมิแพ้, ภาวะเกิดพังผืด, โรคลำไส้อักเสบและมะเร็งป่มน้ำเหลือง Hodgkin The invention relates to the human thymus-suppressive lymphatic system (hTSLP) antibodies and, in particular, those in which the neutralsize the hTSLP act. With a method for applying the anti-hTSLP molecule Antibodies in the diagnosis or treatment of disorders Associated with hTSLP, such as asthma, localized dermatitis, allergic rhinitis, cystic fibrosis, inflammatory bowel disease, and Hodgkin lymphoma.
Claims (3)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH98075B true TH98075B (en) | 2009-09-03 |
| TH98075A TH98075A (en) | 2009-09-03 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007045477A3 (en) | Human antibodies against il-13 and therapeutic uses | |
| WO2010032059A3 (en) | Antibodies directed to cd105 and uses thereof | |
| TNSN08333A1 (en) | Thymic stromal lymphopoietin (tslp) antibodies and uses thereof | |
| WO2009013543A3 (en) | Targeted binging agents directed to kdr and uses thereof - 035 | |
| CY1120874T1 (en) | INTERLEUKIN ANTIBODY SYNTHESIS-13 | |
| CY1120108T1 (en) | ILL-4 AND / OR IL-13 AND ITS USES | |
| WO2010017103A3 (en) | Fully human anti-human nkg2d monoclonal antibodies | |
| WO2013092983A3 (en) | Enzymatic conjugation of polypeptides | |
| WO2009083009A3 (en) | Monoclonal antibodies against cd32b | |
| MA32975B1 (en) | ANTAGONISTS OF C5AR | |
| WO2008112003A3 (en) | Targeted binding agents directed to pdgfr-alpha and uses thereof | |
| EA200800355A1 (en) | NEUTRALIZING HUMAN ANTIBODIES AGAINST B7RP1 | |
| WO2008123999A3 (en) | Anti-ige antibodies | |
| WO2007007173A3 (en) | Human anti-madcam antibodies | |
| WO2006096489A3 (en) | Anti-m-csf antibody compositions having reduced levels of endotoxin | |
| WO2007117400A3 (en) | Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor | |
| WO2010072740A3 (en) | TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREOF | |
| WO2008108830A8 (en) | Immunogenic and therapeutic compositions for streptococcus pyogenes | |
| HK1250237A1 (en) | Il22 immunoconjugates | |
| WO2007064727A3 (en) | Penetrabodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases | |
| WO2013067076A3 (en) | Methods and compositions for neuroprotection | |
| TH98075B (en) | Anti-TSLP Antibody | |
| TH98075A (en) | Anti-TSLP Antibody | |
| WO2011158122A3 (en) | Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof | |
| WO2006024880A3 (en) | Methods and compositions to inhibit p2x7 receptor expression |